These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 24074969

  • 1. [Sustained response with tocilizumab in a case of refractory relapsing polychondritis].
    Weber E, Gaultier JB, Paul S, Guichard I, Monard E, Cathébras P.
    Rev Med Interne; 2014 Mar; 35(3):196-8. PubMed ID: 24074969
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Sustained response to tocilizumab in a patient with relapsing polychondritis complicated by aortitis.
    Sallés M, Mínguez S, Ros S, Tuneu R, Gelman SM.
    Clin Exp Rheumatol; 2017 Mar; 35 Suppl 103(1):223. PubMed ID: 28229816
    [No Abstract] [Full Text] [Related]

  • 4. Sustained Remission with Tocilizumab in Refractory Relapsing Polychondritis with Ocular Involvement: A Case Series.
    Farhat R, Clavel G, Villeneuve D, Abdelmassih Y, Sahyoun M, Gabison E, Sené T, Cochereau I, Titah C.
    Ocul Immunol Inflamm; 2021 Jan 02; 29(1):9-13. PubMed ID: 32643976
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of adalimumab for a refractory case of relapsing polychondritis with reduction of pro-inflammatory cytokines.
    Nakamura H, Suzuki T, Nagaoka K, Yamasaki S, Tamai M, Hayashi T, Kawakami A.
    Mod Rheumatol; 2011 Dec 02; 21(6):665-8. PubMed ID: 21509650
    [Abstract] [Full Text] [Related]

  • 6. Sustained response to tocilizumab, anti-IL-6 antibody, following anti-TNF-α failure in a patient with relapsing polychondritis complicated by aortitis.
    Narshi CB, Allard SA.
    Rheumatology (Oxford); 2012 May 02; 51(5):952-3. PubMed ID: 22298790
    [No Abstract] [Full Text] [Related]

  • 7. Sustained response to tocilizumab in a patient with relapsing polychondritis with aortic involvement: a case based review.
    Stael R, Smith V, Wittoek R, Creytens D, Mielants H.
    Clin Rheumatol; 2015 Jan 02; 34(1):189-93. PubMed ID: 24831688
    [Abstract] [Full Text] [Related]

  • 8. Successful treatment with tocilizumab for refractory scleritis associated with relapsing polychondritis.
    Shimizu H, Nishioka H.
    Scand J Rheumatol; 2017 Sep 02; 46(5):418-419. PubMed ID: 28120637
    [No Abstract] [Full Text] [Related]

  • 9. Relapsing polychondritis: A 2016 update on clinical features, diagnostic tools, treatment and biological drug use.
    Mathian A, Miyara M, Cohen-Aubart F, Haroche J, Hie M, Pha M, Grenier P, Amoura Z.
    Best Pract Res Clin Rheumatol; 2016 Apr 02; 30(2):316-333. PubMed ID: 27886803
    [Abstract] [Full Text] [Related]

  • 10. Biotherapies in large vessel vasculitis.
    Ferfar Y, Mirault T, Desbois AC, Comarmond C, Messas E, Savey L, Domont F, Cacoub P, Saadoun D.
    Autoimmun Rev; 2016 Jun 02; 15(6):544-51. PubMed ID: 26883459
    [Abstract] [Full Text] [Related]

  • 11. Biologic therapy in relapsing polychondritis: navigating between options.
    Padoan R, Campaniello D, Iorio L, Doria A, Schiavon F.
    Expert Opin Biol Ther; 2022 May 02; 22(5):661-671. PubMed ID: 35230215
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of tocilizumab highlighted by FDG-PET/CT in a patient with relapsing polychondritis-associated aortitis.
    Elourimi G, Soussan M, Warzocha U, Bugaud H, Dhôte R, Abad S.
    Rheumatol Int; 2017 Nov 02; 37(11):1931-1935. PubMed ID: 28965131
    [Abstract] [Full Text] [Related]

  • 13. Sustained remission of pediatric relapsing polychondritis with adalimumab.
    Navarrete VM, Lebrón CV, de Miera FJ, Candau CP, Sarabia FN.
    J Clin Rheumatol; 2014 Jan 02; 20(1):45-6. PubMed ID: 24356482
    [No Abstract] [Full Text] [Related]

  • 14. Biologics in relapsing polychondritis: a case series.
    Moulis G, Sailler L, Pugnet G, Astudillo L, Arlet P.
    Clin Exp Rheumatol; 2013 Jan 02; 31(6):937-9. PubMed ID: 24021708
    [Abstract] [Full Text] [Related]

  • 15. A case of life-threatening refractory polychondritis successfully treated with combined intensive immunosuppressive therapy with methotrexate.
    Yamaoka K, Saito K, Hanami K, Nakayamada S, Nawata M, Iwata S, Azuma T, Tanaka Y.
    Mod Rheumatol; 2007 Jan 02; 17(2):144-7. PubMed ID: 17437170
    [Abstract] [Full Text] [Related]

  • 16. Relapsing polychondritis.
    Chopra R, Chaudhary N, Kay J.
    Rheum Dis Clin North Am; 2013 May 02; 39(2):263-76. PubMed ID: 23597963
    [Abstract] [Full Text] [Related]

  • 17. Sustained response to tocilizumab, anti-interleukin-6 receptor antibody, in two patients with refractory relapsing polychondritis.
    Kawai M, Hagihara K, Hirano T, Shima Y, Kuwahara Y, Arimitsu J, Narazaki M, Ogata A, Kawase I, Kishimoto T, Tanaka T.
    Rheumatology (Oxford); 2009 Mar 02; 48(3):318-9. PubMed ID: 19106169
    [No Abstract] [Full Text] [Related]

  • 18. [Diagnosis and treatment of relapsing polychondritis].
    Xu KJ, Liu YH, Jiang M.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Apr 02; 29(2):171-3. PubMed ID: 17536262
    [Abstract] [Full Text] [Related]

  • 19. Relapsing polychondritis: response to tocilizumab and association with colitis.
    Plunkett M, Lamont D, Brooker J, White D.
    J Clin Rheumatol; 2013 Oct 02; 19(7):415-7. PubMed ID: 24048111
    [No Abstract] [Full Text] [Related]

  • 20. Biologics in myelodysplastic syndrome-related systemic inflammatory and autoimmune diseases: French multicenter retrospective study of 29 patients.
    Mekinian A, Dervin G, Lapidus N, Kahn JE, Terriou L, Liozon E, Grignano E, Piette JC, Rauzy OB, Grobost V, Godmer P, Gillard J, Rossignol J, Launay D, Aouba A, Cardon T, Bouillet L, Broner J, Vinit J, Ades L, Carrat F, Salvado C, Toussirot E, Versini M, Costedoat-Chalumeau N, Fraison JB, Guilpain P, Fenaux P, Fain O, GFM, SNFMI, CRI and MINHEMON.
    Autoimmun Rev; 2017 Sep 02; 16(9):903-910. PubMed ID: 28705782
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.